Arbeitsgruppe Schrenk

2020

Steinberg, P., van der Hoet, H., Goedhart, P. W., Kleter, G., Kok, E. J., Pla, M., Nadal, A., Zeljenkova, D., Alacova, R., Babincova, J., Rollerova, E., Jadudova, S., Kebis, A., Szabova, E., Tulinska, J., Liskova, A., Takascova, M., Mikuskova, M. L., Krivosikova, Z., Spök, A., Racovita, M., de Vriend, H., Alison, R., Alison, C., Baumgärtner, W., Becker, K., Lempp, C., Schmicke, M., Schrenk, D., Pöting, A., Scheimann, J., Wilhelm, R. (2020) Correction to: Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphostae-resistant genetically modified maize NK603 in wistar Han RCC rats. Arch Toxicol., Volume 93, 1095-1139.

Schrenk, D., Gao, L., Lin, G., Mahony, C., Mulder, P. P. J., Peijnenburg, A., Pfuhler, S., Rietjens, I. M.C. M., Rutz, L., Steinhoff, B., These, A. (2020)Pyrrolizidine alkaloids in food and phytomedicine: Occurence, exposure, toxicity, mechanisms, and risk assessment - A review. Food Chem Toxicol., Volume 136.

Schrenk, D. (2020) Toxicology of pyrrolizidine alkaloids. Food Chem Toxicol., Volume 135.

Gao, L., Rutz, L., Schrenk, D. (2020) Structure-dependent hepato-cytotoxic potencies of selected pyrrolizidine alkaloids in primary rat hepatocyte culture. Food Chem Toxicol., Volume 135.

Geburek, I., Preiss-Weigert, A., Lahrssen-Wiederholt, M., Schrenk, D., These, A. (2020) In vitro metabolism of pyrrolizidine alkaloids - Metabolic degradation and GSH conjugate formation of different structure types. Food Chem Toxicol., Volume 135.

Cartus, A. T., Schrenk,D. (2020) Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes. Arch Pharmacol., Volume 339 (2), 213-223.

 

 

Zum Seitenanfang